Skip to main content
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Brian Macomson, PharmD
Associate Director
Translational Science Team
Health Economics and Outcomes Research
Janssen Scientific Affairs
Raritan, NJ
Associate Director, Translational Science Team, Health Economics and Outcomes Research, Janssen Scientific Affairs, Raritan, NJ
Authored Items
Evaluating Drug Cost per Response with SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus
Janice M.S. Lopez, PharmD, MPH
,
Brian Macomson, PharmD
,
Varun Ektare, MPH
,
Dipen Patel, PhD
,
Marc Botteman, MSc
,
Quang T. Nguyen, DO, FACE, FTOS
September 2015 Vol 8, No 6
in
Practice Management
Anticoagulant Use for Prevention of Stroke in a Commercial Population with Atrial Fibrillation
Aarti A. Patel, PharmD, MBA
,
Jack E. Fincham, PhD, RPh
,
Barbara Lennert, RN, BSN, MAOM
,
Brian Macomson, PharmD
,
Winnie W. Nelson, PharmD
,
Gary M. Owens, MD
,
Samir H. Mody, PharmD, MBA
,
Jeff Schein, DrPH, MPH
July/August 2012, Vol 5, No 5
in
Original Research
Last modified: September 29, 2015
